Biogen Inc. (ETR:IDP)
133.00
-1.45 (-1.08%)
Nov 7, 2025, 5:35 PM CET
Biogen Market Cap
Biogen has a market cap or net worth of €19.7 billion as of November 7, 2025. Its market cap has decreased by -20.30% in one year.
Market Cap
19.70B
Enterprise Value
21.97B
Revenue
8.58B
Ranking
n/a
PE Ratio
14.37
Stock Price
€133.00
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 126.71M to 19.70B, an increase of 15,448.22%. That is a compound annual growth rate of 15.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 19.70B | -8.46% |
| Dec 31, 2024 | 21.52B | -36.55% |
| Dec 29, 2023 | 33.92B | -9.09% |
| Dec 30, 2022 | 37.31B | 20.41% |
| Dec 31, 2021 | 30.99B | 0.60% |
| Dec 31, 2020 | 30.80B | -35.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 48.17B |
| Merck KGaA | 47.59B |
| Fresenius SE & Co. KGaA | 26.83B |
| Bayer Aktiengesellschaft | 25.60B |
| Sartorius Aktiengesellschaft | 13.70B |
| Fresenius Medical Care AG | 11.99B |
| Fielmann Group AG | 3.72B |
| Carl Zeiss Meditec AG | 3.72B |